Ripal Suthar is a seasoned Regulatory Affairs Specialist with a strong background in developing and executing regulatory strategies across various regions, including the MHRA, EU, Canada, South Africa, and GCC at PPD since July 2021. Previously, Ripal served as a Regulatory Affairs Executive at Nivagen Pharmaceuticals, Inc., where responsibilities included preparing and submitting ANDAs in eCTD format and managing regulatory compliance. Prior experience also includes working as a Regulatory Affairs Senior Consultant at DXC Technology, where Ripal built submissions for NDA and IND, and as a Jr. Officer at Apothecon Pharmaceutical, focusing on DMF, ASMF, and ANDA submissions. Educational qualifications include a Master of Pharmacy in Quality Assurance and Regulatory Affairs from L.J. Institute Of Pharmacy and a Bachelor of Pharmacy from Dharmaj Degree Pharmacy College.